BioSpace News Archive

Drug Development

KOSAN Biosciences, Inc.'s Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial; Data Presented at American Society of Clinical Oncology Show 26% Partial Respons

June 3, 2008
·
7 min read
Business

Arana Therapeutics and greenovation Biotech GmbH Enter Into a Collaboration Agreement

June 3, 2008
·
1 min read
Business

Cardiome Pharma Corp. Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor

June 3, 2008
·
9 min read
Deals

Berkeley’s Oncologic Merges with Triton BioSystems, Inc. to Create New Cancer Treatment Company, Aduro BioTech

June 3, 2008
·
3 min read
BioCapital

Osiris Therapeutics, Inc. to Present at the Canaccord Adams Diabetes and Obesity Conference

June 3, 2008
·
1 min read
Business

454 Life Sciences, Cogenics, and Limagrain to Jointly Develop Solutions for Crop SNP Discovery with Next Generation Sequencing

June 3, 2008
·
1 min read
Biotech Bay

XenoPort, Inc. to Present at the Goldman, Sachs & Co. Healthcare Conference

June 3, 2008
·
1 min read
Pharm Country

Pfizer Inc. Reviews Progress of Oncology Pipeline and New Commercial Business Unit Structure with Analysts

June 3, 2008
·
1 min read
Drug Development

New Pfizer Inc. Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing’s Sarcoma

June 3, 2008
·
1 min read
BioMidwest

Spectranetics Corporation to Present at the Goldman, Sachs & Co. and Jefferies Healthcare Conferences in June

June 3, 2008
·
1 min read